D.E. Shaw & Co’s iKang Healthcare Group, Inc. KANG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-12,765
Closed -$186K 3640
2017
Q1
$186K Buy
+12,765
New +$210K ﹤0.01% 3135
2016
Q1
Sell
-31,284
Closed -$639K 3958
2015
Q4
$639K Buy
+31,284
New +$540K ﹤0.01% 2926
2015
Q2
Sell
-20,590
Closed -$334K 3968
2015
Q1
$334K Buy
20,590
+990
+5% +$16.5K ﹤0.01% 3257
2014
Q4
$295K Buy
+19,600
New +$349K ﹤0.01% 3651
2014
Q3
Sell
-10,834
Closed -$188K 4549
2014
Q2
$188K Buy
+10,834
New +$163K ﹤0.01% 4004

Other funds holding KANG

D.E. Shaw & Co's KANG Position: Q2 2017 in Review

D.E. Shaw & Co sold out of iKang Healthcare Group, Inc. (KANG) in Q2 2017, closing a stake of 12,765 shares — an estimated $186K sold.

D.E. Shaw & Co first reported a position in KANG in Q2 2014 and held it in 5 quarters. The position peaked at $639K in Q4 2015. 52 funds tracked by Wall St. Rank hold KANG as of Q2 2017.

  • D.E. Shaw & Co reported no remaining iKang Healthcare Group, Inc. position as of Q2 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 12,765 iKang Healthcare Group, Inc. shares in Q2 2017, an estimated $186K.
  • D.E. Shaw & Co first reported a position in iKang Healthcare Group, Inc. in Q2 2014 and held it in 5 quarters.
  • D.E. Shaw & Co's iKang Healthcare Group, Inc. position peaked at $639K in Q4 2015.
  • 52 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q2 2017.

Based on D.E. Shaw & Co's 13F filing for Q2 2017, filed 14 Aug 2017.